Completed PHASE4 INTERVENTIONAL NCT00447434

Efficacy and Safety of Natto Extract

An Open-Label, Parallel Comparison Study to Evaluate the Effect of Oral Administration of Nattokinase Taken by Normal Subjects, Patients Under Dialysis, and Patients of Cardiovascular High Risk Groups

Sponsor: Changhua Christian Hospital

Conditions Cardiovascular Diseases Thrombosis

Interventions Natto extract (Nattokinase)

Updated 4 times since 2017 Last updated: Mar 13, 2007 Started: Jun 30, 2005 Completion: Oct 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00447434, this PHASE4 trial focuses on Cardiovascular Diseases and Thrombosis and remains completed. Sponsored by Changhua Christian Hospital, it has been updated 4 times since 2005, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2017 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Jun 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Changhua Christian Hospital

Data source: Changhua Christian Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Changhua, Taiwan